Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Adipose tissue explant culture using PDMS flow chambers: an alternative to static explant culture

Cohen M., Bandaru P., Szylo K., Nguyen N., Nadeak B., Paszkiewicz R.

Laboratory Study on Face & Skin, published in Adipocyte (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Adipocyte (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41132053
PMCID
PMC12562731
DOI
10.1080/21623945.2025.2578286

Abstract (original English)

As obesity rates continue to rise, it is important that we can effectively study adipose tissue to understand its physiological contribution in individuals with obesity. Unfortunately, due to the fragility and buoyancy of adipose tissue, culture remains challenging. Ex vivo culture of tissue explants is possible, however after 48 hours explants often display declining viability, increased inflammation, and de-differentiation. Other common approaches include differentiation of preadipocytes and adipocyte isolation by enzymatic dissociation, however these methods are time-consuming and fail to recapitulate the structure and cellular network within adipose tissue. Given these shortcomings, we developed a novel explant culture method using polydimethylsiloxane (PDMS) flow chambers attached to a micro peristaltic pump. This approach reduces air interface while enabling media perfusion, time-resolved measurements of secreted factors, and easy incorporation of treatments. Using our chambers, we assessed viability with resazurin and lactate dehydrogenase (LDH) assays, physiology by measuring glycerol release, architecture by confocal imaging, and retention of adipose gene expression by qPCR. Explants remained viable for over 72 hours. Resazurin reduction was at 84 ± 9% of baseline, and LDH release remained low. Isoproterenol treatment resulted in 2.7 ± 0.5-fold increased glycerol relea

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAdipocytesHumansDimethylpolysiloxanesTissue Culture Techniques

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research